Clinical trials
Active, not recruiting Recurrence trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 5 |
| Celgene | 4 |
| Novartis Pharmaceuticals | 3 |
| Fondazione Italiana Linfomi - ETS | 2 |
| Genmab | 2 |
| Hoffmann-La Roche | 2 |
| Pfizer | 2 |
| Amgen | 1 |
| Andrés José Maria Ferreri | 1 |
| BioNTech SE | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 32 |
| Lymphoma, Follicular | 5 |
| Multiple Myeloma | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasms | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Myelodysplastic Syndromes | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.